More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm any anti-cancer benefit.

A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen studies presented over the past few days at the American Society of Clinical Oncology meeting in ‌Chicago found that patients taking…

Over two dozen studies found that patients taking the drugs showed lower risks of developing cancer. Read more at straitstimes.com. Read more at straitstimes.com.

Over two dozen studies found that patients taking the drugs showed lower risks of developing cancer. Read more at straitstimes.com. Read more at straitstimes.com.

Over two dozen studies found that patients taking the drugs showed lower risks of developing cancer. Read more at straitstimes.com. Read more at straitstimes.com.

GLP-1 drugs may reduce cancer progression and improve survival rates, according to recent studies presented at ASCO.